Back

Efficacy and safety of single-pill combination perindopril/amlodipine switched from combinations of other renin-angiotensin system inhibitors and calcium channel blockers: results from ESPRIT trial

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Treatment of hypertension Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Qiran Liang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Comparing adrenalectomy and mineralocorticoid receptor antagonists in primary aldosteronism: a systematic review and meta-analysis of cardiac outcomes
Doctor F. Zoccatelli (Verona, IT)
Abstract Slides Video
Presentation thumbnail
Effects of intensive systolic blood pressure control in diabetic patients: a systematic review and meta-analysis comparing <120 mmHg vs. <140 mmHg targets
Doctor J. Giorgi (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Comparison of cardiovascular outcomes between chlorthalidone and hydrochlorothiazide in hypertensive patients
Assistant Professor S. Lim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Sustained control of systolic blood pressure and resting heart rate within target ranges improve cardiovascular outcomes in patients with hypertension
Professor Y. Chen (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
The comparative antihypertensive efficacy of torasemide and mineralocorticoid receptor antagonists in patients with resistant hypertension
Professor L. Mishchenko (Kyiv, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of hypertension

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Real-world analysis exploring the association between anti-hypertensive therapy with perindopril-based single-pill combinations (SPC) and cardiovascular outcomes and all-cause mortality in Italy
thumbnail
Congress Presentation
Single-pill low-dose triple combination therapy versus standard-dose monotherapy in patients with mild to moderate hypertension: results from two randomized clinical trials
thumbnail
Congress Presentation
The effect of fixed combination of medications (lisinopril 5mg + amlodipine 5mg + rosuvastatin 10mg) on some parameters of 24-hour blood pressure monitoring in patients with arterial hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources